Published in Lab Business Week, April 30th, 2006
BrainStorm Cell Therapeutics Inc. is an emerging company developing neural-like stem cell therapeutic products, NurOwn, based on autologous bone marrow derived stromal cells, for treatment of neurodegenerative diseases. NurOwn patent pending technology is based on discoveries made by the team of neurologist, Eldad Melamed, head of neurology at Rabin Medical Center, and ecell biologist Daniel Offen at the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week